How Miriam Merad’s research is rewriting the rules of cancer immunotherapy

A joke among Merad's colleagues is that scientists who go into a room with her come back out as macrophage biologists

October 28, 2025 Check out STAT+

Sponsored By

Chantal Heijnen for STAT STAT+ | Miriam Merad's 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy After decades studying macrophages, Miriam Merad believes these overlooked immune cells could unlock a new frontier in cancer treatment. By Angus Chen STAT+ | Chinese biotech industry shows no signs of slowing as threat of U.S. restrictions loom  Drugmakers — once seen as a source of "me-too" drugs — are advancing at a rapid clip, churning out novel medications and threatening to overtake the U.S. By Brian Yang STAT+ | Hope and 'no regrets': How pancreatic cancer surgeon Dr. Michael Zinner faced a pancreatic cancer diagnosis After years of treating pancreatic cancer, Dr. Michael Zinner noticed something amiss with himself: "I absolutely know how this movie ends." By Bryan Marquard — Boston Globe SCIENCE PHOTO LIBRARY STAT+ | CAR-T therapies from Cabaletta, Bristol Myers Squibb induce remissions in patients with autoimmune disorders Small trials add to evidence personalized cell therapies may prove to be curative for patients with serious autoimmune disorders. By Adam Feuerstein

More around STAT

---

In case you missed it Scientists demand cancer warnings on bacon and ham sold in UK, the Guardian. China's Innovent strikes cancer drug deal with Takeda for up to $11.4 Billion, Wall Street Journal. The mysterious rise of cancer among young adults in the Corn Belt, Washington Post.

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser